Myeloproliferative disorders and the hyperviscosity syndrome
- PMID: 20488356
- DOI: 10.1016/j.hoc.2010.03.004
Myeloproliferative disorders and the hyperviscosity syndrome
Abstract
Myeloproliferative disorders and the serum hyperviscosity syndrome can rapidly manifest with emergent presentations. Hyperviscosity occurs from pathologic elevations of either the cellular or acellular (protein) fractions of the circulating blood. Classic hyperviscosity syndrome presents with the triad of bleeding diathesis, visual disturbances, and focal neurologic signs. Emergency medicine providers should be aware of these conditions and be prepared to rapidly initiate supportive and early definitive management, including plasma exchange and apharesis. Early consultation with a hematologist is essential to managing these complex patients.
Copyright 2010 Elsevier Inc. All rights reserved.
Republished from
-
Myeloproliferative disorders and the hyperviscosity syndrome.Emerg Med Clin North Am. 2009 Aug;27(3):459-76. doi: 10.1016/j.emc.2009.04.001. Emerg Med Clin North Am. 2009. PMID: 19646648 Review.
LinkOut - more resources
Full Text Sources
